Premium
Rat somatostatin sst 2(a) and sst 2(b) receptor isoforms mediate opposite effects on cell proliferation
Author(s) -
Alderton Forbes,
Fan TaiPing D.,
Schindler Marcus,
P A Humphrey Patrick
Publication year - 1998
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0702282
Subject(s) - pertussis toxin , somatostatin , endocrinology , medicine , receptor , cell growth , somatostatin receptor , somatostatin receptor 2 , biology , somatostatin receptor 3 , g protein , biochemistry
We have investigated the actions of somatostatin (SRIF) and angiopeptin on cell proliferation of CHO‐K1 cells expressing the recently cloned rat sst 2(b) receptor (CHOsst 2(b) ) and compared these to their effects in cells expressing the sst 2(a) receptor (CHOsst 2(a) ). In contrast to the sst 2(a) receptor, the sst 2(b) receptor did not mediate inhibition of bFGF (10 ng ml −1 )‐stimulated re‐growth and cell proliferation. Rather, SRIF (0.1–1000 n M ) and angiopeptin (0.1–1000 n M ) stimulated basal re‐growth and proliferation of CHOsst 2(b) cells in a concentration‐dependent manner (estimated pEC 50 values of 7.8 and 7.9, respectively). The opposite effects of SRIF on cell proliferation mediated through the two sst 2 receptor isoforms were both abolished by 18 h pre‐treatment with pertussis toxin. The proliferative effect via the sst 2(b) receptor was also abolished by the tyrosine kinase inhibitor, genistein. In conclusion, the present study shows that the rat sst 2(a) and sst 2(b) receptor splice variants mediate opposite effects on cell proliferation.